Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

IRMD iRadimed Corporation
$83.93 -0.02% -0.02
Notify me if price changes either direction
Interactive Brokers Logotype

Buy IRMD stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

iRadimed Corporation (IRMD)

Loading

Key Stats

Market cap. 1.1B
Enterprise value 1.0B
Trailing PE 46.89944
Forward PE 34.218796
PEG Ratio -5.276187
Enterprise to EBITDA 34.758
Enterprise to revenue 11.749
Price to book MRQ 10.550459
Price to sales TTM 12.433318

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 86.3M
EBITDA 29.2M
Diluted EPS TTM 1.79
Total Cash (MRQ) 59.1M
Current ratio (MRQ) 9.463
Operating Cash Flow (TTM) 27.1M

IRMD trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent IRMD News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.